GREM1 and chronic kidney disease: These data show that inhibition of VEGFR2 signaling ameliorates renal fibrosis and suggest that Gremlin/VEGFR2 blockade could be responsible of the downregulation of profibrotic events, suggesting a novel anti-fibrotic therapy for CKD.